The Ethics of Placebo in Studies with Fracture End Points in Osteoporosis
- 30 September 2010
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 363 (14) , 1367-1370
- https://doi.org/10.1056/nejmsb1006120
Abstract
This article presents one viewpoint on the issues surrounding placebo-controlled trials in osteoporosis. The other Sounding Board article in this issue presents an opposing view. In a related interactive feature, the authors of each article give their Point of View about the other article. Participate in forming community opinion by choosing one of the viewpoints and, if you like, providing your reasons.Keywords
This publication has 32 references indexed in Scilit:
- Lasofoxifene in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2010
- Increasing Options for the Treatment of OsteoporosisNew England Journal of Medicine, 2009
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- The Effects of Tibolone in Older Postmenopausal WomenNew England Journal of Medicine, 2008
- Effects of long‐term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five‐year, randomized, placebo‐controlled trialArthritis & Rheumatism, 2008
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with OsteoporosisAnnals of Internal Medicine, 2007
- A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosisHealth Technology Assessment, 2005
- IX: Summary of Meta-Analyses of Therapies for Postmenopausal OsteoporosisEndocrine Reviews, 2002